Alivus Life Sciences Ltd.

NSE: ALIVUS | BSE: 543322 | ISIN: INE03Q201024 | Industry: Pharmaceuticals
| Expensive Performer
1036.3000 2.70 (0.26%)
NSE Apr 25, 2025 15:31 PM
Volume: 100.9K
 

logo
Alivus Life Sciences Ltd.
27 Jan 2023
1036.30
0.26%
buy
by BOB Capital Markets Ltd.
Target: 585
BOB Capital Markets Ltd.
Q3 revenue up 6% QoQ to Rs 5.4bn supported by sequential recovery in API business to parent and PLI benefits
 
Alivus Life Sciences Ltd. has gained 38.08% in the last 1 Year
More from Alivus Life Sciences Ltd.
Recommended
Five Interesting Stocks Today - April 25, 2025
The Baseline | 25 Apr 2025, 05:30PM
Market closes lower, Maruti Suzuki's Q4 net profit misses Forecaster estimates by 4%
Trendlyne Marketwatch | 25 Apr 2025, 03:56PM
Glenmark Life Sciences: The hived off API business of Glenmark Pharma goes public
| 27 Jul 2021